Source link : https://www.newshealth.biz/health-news/cah-drug-under-review-gender-affirming-surgery-in-kids-cgms-for-non-diabetics/
The FDA accepted Neurocrine Bioscience’s new drug applications with priority review for crinecerfont, an investigational treatment for pediatric and adult patients with classic congenital adrenal hyperplasia (CAH), based on data from the CAHtalyst trials. If approved, it would be the first new treatment option for CAH in 70 years. A study showed that a growth […]
Author : News Health
Publish date : 2024-07-01 16:14:39
Copyright for syndicated content belongs to the linked Source.
Categories